Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Sexual dissatisfaction in postmenopausal women not linked to cardiovascular disease

Sexual dissatisfaction in postmenopausal women not linked to cardiovascular disease

April 03, 2008

Although sexual dysfunction in some men is predictive of cardiovascular disease, this association has never been examined in women. In an article published in the April 2008 issue of The American Journal of Medicine, researchers found no increased prevalence or incidence of cardiovascular disease among postmenopausal sexually active female subjects who were dissatisfied with their sexual activity.

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) and collaborators nationwide examined data from over 93,000 women in the Women's Health Initiative Observational Study. Participants were sexually active postmenopausal women aged 50 to 79 years, recruited at 40 clinical centers throughout the United States and followed for 8-12 years. Based on responses to a baseline survey, subjects were classified as sexually satisfied or dissatisfied.




Researchers identified cardiovascular disease as a self-reported history of acute myocardial infarction, stroke, or coronary revascularization procedure. Related cardiovascular problems, including congestive heart failure, peripheral arterial disease and angina were also examined.

According to researchers, there was a modest association between being dissatisfied with sexual activity and having peripheral arterial disease, and angina was decreased among those dissatisfied with sexual activity. However, there was no association between sexual dissatisfaction and the presence of any other form of cardiovascular disease including heart attack or stroke.

Writing in the article, Jennifer McCall-Hosenfeld, MD, MSc, a fellow in the Department of General Internal Medicine at BMC and Women's Health at BUSM, states, "In men, erectile dysfunction is a manifestation of cardiovascular disease, and can predict the development of adverse cardiovascular outcomes such as heart attack. In our study, we used decreased sexual satisfaction as a rough proxy measure for sexual dysfunction, and controlled for lifestyle issues and other factors that might impact sexual satisfaction. We did not find that sexual satisfaction predicted cardiovascular disease in the future."

Elsevier Health Sciences



Related Postmenopausal Current Events and Postmenopausal News Articles Postmenopausal Current Events and Postmenopausal News RSS Postmenopausal Current Events and Postmenopausal News RSS
Menopause-cardiology consensus statement on cardiovascular disease and on HRT
A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT.

Mayo researchers find robotic repair for vaginal prolapse has significant benefits
New Mayo Clinic research has found that robotic surgery for vaginal prolapse dramatically reduces patient hospital stay and recovery time.

Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.

Postmenopausal women with higher testosterone levels
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels.

Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women.

Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent
SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

Researchers believe hormone therapy should not be stopped prior to mammograms
Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings.

Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance
The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop.

Postmenopausal women benefit from endurance training as much as younger women
Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples.

Seizure drug enhances sleep for women with hot flashes
Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health.
More Postmenopausal Current Events and Postmenopausal News Articles
Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 3rd Edition

Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 3rd Edition
by Rogerio A. Lobo (Editor)

For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic work combines the best from two well-known references: Menopause, and the second edition of Treatment of the Postmenopausal Woman. By adding significant discussions of the basic science behind menopause, it is possible to objectively assess the clinical value and limitations of current approaches to treatment and provide a basis and rationale for strategies that will result in better individualized and specialized care. Not only does the third edition discuss diagnosis and treatment of menopause but it covers biological, anatomical, physiological, pathobiological, and pharmacological aspects as well bringing together, in one source, all of the information needed to understand and treat postmenopausal...

Femgest Progesterone 2/2 fl oz Cream

Femgest Progesterone 2/2 fl oz Cream
by Home Health

An organically based form of progesterone cream designed for women of all ages, FemGest provides a gentle, holistic approach to your body's need for balance. Featuring progesterone combined with soothing aloe vera and grapefruit extract, FemGest is ideal for those times when you want a supportive, soothing cream that harmonizes with your unique nature.

  Peri- and Postmenopausal Mood and Associated Symptoms



Healthy Aging Nutraceuticals Osteo Support 120 Tab

Healthy Aging Nutraceuticals Osteo Support 120 Tab
by Healthy Aging Nutraceuticals

Healthy bones need more than just calcium, and this is the best product we have found. A combination mineral, nutrient and herbal formulation, Osteo Support contains all the supplements you need to build and protect bones. We use it most often for bone injuries and for pre- and postmenopausal women who want a good quality calcium supplement.

  SECOND SLUTHOOD: A MANIFESTO FOR THE POST-MENOPAUSAL, PRE-SENILIC MATRIARCH
by River City Publishing (Publisher)



  Hormone therapy debate continues post WHI: the effects of postmenopausal HT on both heart disease risk and breast cancer risk remain unclear.(Women's Health): An article from: Internal Medicine News
by Bruce K. Dixon (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on November 1, 2006. The length of the article is 1698 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Hormone therapy debate continues post WHI: the effects of postmenopausal HT on both heart disease risk and breast cancer risk remain unclear.(Women's Health)
Author: Bruce K. Dixon
Publication: Internal Medicine News (Magazine/Journal)
Date: November 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 21 Page: 24(1)

Distributed by Thomson...

Postmenopausal Hormone Therapy: Weighing the Benefits and Risks (NCME Video 695)

Postmenopausal Hormone Therapy: Weighing the Benefits and Risks (NCME Video 695)
Also With: Leon Speroff (Primary Contributor), Network For Continuing Medical Education (Primary Contributor)



  Close follow-up OK for many small ovarian cysts. (Asymptomatic Postmenopausal Women).: An article from: Family Practice News
by Sherry Boschert (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2003. The length of the article is 611 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Close follow-up OK for many small ovarian cysts. (Asymptomatic Postmenopausal Women).
Author: Sherry Boschert
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 3 Page: 41(1)

Distributed by Thomson...

  Primary Hyperparathyroidism of Post-Menopausal Women: Prospective Population-Based Case-Control Analysis on Prevalence, Clinical Findings and Treatment ... Summaries of Uppsala Dissertations, 820)
by Ewa Lundgren (Author)



  Raloxifene linked to reduced risk of stroke, TIA. (In High-Risk, Postmenopausal Women).(transient ischemic attack): An article from: Internal Medicine News
by Mitchel L. Zoler (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2003. The length of the article is 996 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Raloxifene linked to reduced risk of stroke, TIA. (In High-Risk, Postmenopausal Women).(transient ischemic attack)
Author: Mitchel L. Zoler
Publication: Internal Medicine News (Magazine/Journal)
Date: January 15, 2003
Publisher: International Medical News Group
Volume: 36 Issue: 2 Page: 45(1)

Distributed by Thomson...

© 2009 BrightSurf.com